Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Operating Expenses | 261,627 | 234,773 | 177,080 | 118,314 | 79,955 |
| Operating Income | -261,627 | -234,773 | -177,080 | -118,314 | -79,955 |
| Interest Expense | 7,893 | 6,660 | 4,160 | 2,223 | 3,060 |
| Other Income | 22,691 | 26,047 | 7,244 | 2,501 | 2,145 |
| Pre-tax Income | -246,829 | -215,386 | -173,996 | -118,036 | -80,870 |
| Income Tax | 468 | 408 | 288 | N/A | N/A |
| Net Income Continuous | -247,297 | -215,794 | -174,284 | -118,036 | -80,870 |
| Net Income | $-247,297 | $-215,794 | $-174,284 | $-118,036 | $-80,870 |
| EPS Basic Total Ops | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EPS Basic Continuous Ops | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EPS Diluted Total Ops | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EPS Diluted Continuous Ops | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EPS Diluted Before Non-Recurring Items | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EBITDA(a) | $-267,072 | $-244,444 | $-180,271 | $-113,947 | $-76,868 |